Going ‘nano’ on Parkinson’s disease in Mexico

The Center for Research and Advanced Studies (Cinvestav) is a national leader in scientific research, technology development and the formation of highly educated professionals in Mexico. Cinvestav is now expanding its reach globally with a nanoparticle-based therapy for Parkinson’s disease that represents an opportunity for international partnerships. To download the full article, please sign in.

Like 0 Comment
Page of
Go to the profile of Cinvestav


The Cinvestav was created in 1961 by presidential decree as a public agency with legal personality and its own assets. Its founding director, Dr. Arturo Rosenblueth, prompted a formal demand that has resulted in the success of the institution. The Cinvestav has twenty-eight research departments that are distributed by the nine campuses throughout Mexico.

No comments yet.